Background: The decision to proceed with vascular surgical interventions requires evaluation of cardiac risk. Recently, several online risk calculators were created to predict outcomes and to lead to a more informed conversation between surgeons and patients. The objective of this study was to compare and further validate these online calculators with actual adverse cardiac outcomes at a single institution.
Coronary artery disease is a significant cause of morbidity and mortality in patients undergoing peripheral vascular surgery. It is estimated that up to 50% of all patients undergoing a vascular operation have some degree of coronary disease, and up to 10% of asymptomatic patients have severe coronary disease on angiography. 1 The assessment of probability of an adverse cardiac event (ACE) is paramount to the preoperative discussion for any operation. Many organizations have attempted to quantify the probability of ACE and have created easily accessible online portals for providers. The American College of Surgeons National Surgical Quality Improvement Program (NSQIP) is a data reporting system for hospitals. The current database features >500 hospitals and millions of operations within the last 10 years, including vascular surgery. The risk calculator is procedure specific based on Current Procedural Terminology codes. The calculator predicts multiple variables including a "cardiac complication," defined as a cardiac arrest or myocardial infarction (MI). MI can be diagnosed by electrocardiographic (ECG) changes, serum troponin elevation, or a physician's diagnosis. The calculator is updated periodically as more data are entered into NSQIP. The cardiac complication model is validated with C statistic of 0.895. 2, 3 The Revised Cardiac Risk Index (RCRI) was created after a review of >4000 noncardiac, nonemergent operations performed at a single institution (Brigham and Women's Hospital, Boston, Mass) >20 years ago. Vascular operations, both major aortic and minor arterial, were specifically under-represented in the initial sample. The calculated outcome is a "major cardiac event," defined as MI, pulmonary edema, ventricular fibrillation or primary cardiac arrest, and complete heart block. MI was defined as serum creatine kinase MB isoenzyme (CK-MB) elevation with or without ECG changes. The model was validated with a C statistic of 0.77. 4 The Vascular Study Group of New England (VSGNE) is a regional collection of institutions participating in the Society for Vascular Surgery Vascular Quality Initiative (VQI) database. The risk calculator was developed using an analysis of >88,000 patients undergoing carotid endarterectomy (CEA), infrainguinal lower extremity bypass, open abdominal aortic aneurysm (AAA) repair, and endovascular aneurysm repair (EVAR) during a 5-year period (2012) (2013) (2014) (2015) (2016) . Each operation has its own risk calculator to estimate the probability of in-hospital postoperative MI, defined by serum troponin elevation, clinical criteria, or ECG changes. The models were internally validated with a C statistic of 0.75 and externally validated with a C statistic of 0.76. 5 The objective of this study was to compare and to validate the use of the NSQIP, RCRI, and VSGNE risk calculators in estimation of ACE in patients undergoing vascular operations at a single institution.
METHODS
As a quality project using retrospective data, the study received Institutional Review Board exemption status from the University of Virginia Institutional Review Board for Health Science Research. Informed consent was not obtained because all data were acquired through retrospective chart review and calculated in a confidential and deidentified manner.
Consecutive patients who underwent CEA, infrainguinal lower extremity bypass, open AAA repair, and EVAR from January 2011 through December 2015 at a single institution through the vascular surgery service were identified using the VQI database. Additional information was obtained through retrospective chart review. All data were recorded in Excel spreadsheet (Microsoft, Redmond, Wash).
Interrogation of VQI database revealed 865 patients, nine of whom were removed from the study because of incomplete data collection. A total of 856 patients were included in the study. Recommendation: This study suggests that the predictive ability of cardiac risk calculators is variable and suboptimal and that they generally underestimate cardiac risk.
nitrate therapy, or ECG with pathologic Q waves. One point was assigned for history of CHF: pulmonary edema, bilateral rales or S 3 gallop, paroxysmal nocturnal dyspnea, or chest radiograph showing pulmonary vascular redistribution. One point was assigned for history of cerebrovascular disease: prior transient ischemic event or stroke. One point was assigned for preoperative treatment with insulin. One point was assigned for creatinine concentration >2 mg/dL. Risk is calculated as follows: 0 points, 0.4% risk of major cardiac event; 1 point, 0.9% risk of major cardiac event; 2 points, 6.6% risk of major cardiac event; 3 or more points, 11% risk of major cardiac event. Risk of major cardiac event was recorded.
The patient's preoperative information was entered into one of four operation-specific VSGNE risk calculators. Each calculator asked for various combinations of the following variables: age, creatinine level >1.8 mg/dL, results of stress test within 2 years, history of coronary artery disease, history of coronary artery bypass graft or percutaneous coronary intervention, history of CHF, diabetes, history of prior vascular surgery (defined as CEA, carotid angioplasty or stenting, noncardiac bypass, arterial aneurysm, major lower extremity amputation, or peripheral vascular intervention), race, chronic obstructive pulmonary disease, planned level of Statistical methods. Observed ACE outcomes were determined using the VQI database and confirmed with retrospective chart review. The observed ACE for NSQIP included cardiac arrest and MI. Patients documented as "dysrhythmia" in the VQI database were excluded if further clarification revealed atrial fibrillation or atrial flutter. Each calculator predicted separate ACEs, and the observed ACE reflects the individual definitions. Of note, the VQI database defines MI by either serum troponin elevation or ECG or clinical criteria. The VQI definition of MI correlates with the NSQIP and VSGNE definitions but not with the RCRI definition (serum CK-MB elevation with or without ECG changes). Observed ACE was compared with expected values from each calculator using the c 2 test. Descriptive analysis of subgroups was calculated using the two-tailed sample t-test for difference of means. Statistical significance was indicated by a P value < .05.
RESULTS
There were 350 patients who underwent CEA during the study period (Table) ; 7 (2%) suffered an ACE There were 77 patients who underwent open AAA repair during the study period. The NSQIP predicted 6.4 ACEs and 8 (10.4%) were observed (P ¼ .5). The RCRI predicted 3.7 ACEs and 18 (23.4%) were observed (P # .0001). The VSGNE predicted 2.95 ACEs and 3 (3.9%) were observed (P ¼ .98). The RCRI underpredicted the associated ACE, whereas the NSQIP and VSGNE appropriately predicted ACE. Further analysis was conducted among the RCRI group. The subgroup of the patients with observed RCRI-defined ACE had a mean calculated risk of 5.9% and the remaining 59 patients had a mean calculated risk of 4.4%, without significant difference (P ¼ .104).
There were 219 patients who underwent EVAR during the study period. The NSQIP predicted 4.96 ACEs and 10 (4.5%) were observed (P ¼ .021), with no difference of mean estimated risk between subgroups (2.2% without ACE and 3.6% with ACE; P ¼ .25). The RCRI predicted 9.69 ACEs and 21 (9.6%) were observed (P ¼ .0002), with no difference in mean estimated risk between subgroups (4.5% without ACE vs 4.2% with ACE; P ¼ .76). The VSGNE predicted 3.1 ACEs and 7 (3.2%) were observed (P ¼ .025), with no difference in mean estimated risk between subgroups (13% without ACE vs 2.5% with ACE; P ¼ .50). The NSQIP, RCRI, and VSGNE strongly underpredicted ACEs by half in patients undergoing EVAR. A pooled sample of 856 patients undergoing CEA, infrainguinal bypass, open AAA, and EVAR was created. The NSQIP predicted 20.5 ACEs and 33 (3.8%) were observed (P ¼ .0055). The RCRI predicted 30.9 ACEs and 69 (8%) were observed (P # .0001). The VSGNE predicted 18 ACEs and 22 (2.6%) were observed (P ¼ .345). The VSGNE adequately predicted ACEs, whereas the Further analysis of patients who underwent preoperative stress testing was conducted (Fig) . At our institution, stress tests are performed at the operating surgeon's discretion or are recorded if the information was previously available. There were 470 patients who had documented stress tests (55% of the total sample), and 160 of the test results (34%) were abnormal. Abnormal stress test results showed ischemia or prior infarction. Of the 33 ACEs that occurred as defined by the NSQIP, 48% had no stress test and 27% had an abnormal stress test result. Of the 69 ACEs that occurred as defined by the RCRI, 36% had no stress test and 31.8% had an abnormal stress test result. Of the 13 ACEs that occurred as defined by the VSGNE, 40% had no stress test and 37% had an abnormal stress test result. Descriptive analysis of the sample that underwent stress testing compared with the sample that did not undergo stress testing revealed no significant difference in proportion of observed ACE (among all three calculators) and no significant difference in calculated risk of ACE. However, the RCRI data revealed an absolute difference in percentages of observed ACE among the subgroups (6.5% without stress test, 9.4% with stress test; P ¼ .45) and a trend to significance in difference of risk of ACE (3.3% without a stress test, 3.9% with a stress test; P ¼ .06). Because of the low incidence of ACE and only half the population's having documented stress tests, positive and negative predictive values are unreliable.
DISCUSSION
This study confirms the high prevalence of coronary artery disease in patients with peripheral atherosclerotic and aneurysm disease and further documents higher than expected rates of clinically relevant disease. The primary objective was to validate three widely available risk calculators for quantification of an individual's perioperative outcomes. The NSQIP proved an adequate predictor of ACE for three individual operations (CEA, open AAA, and infrainguinal bypass) but not for EVAR or for a pooled sample. The RCRI only adequately predicted ACE for CEA. The VSGNE risk calculator was the most successful and underpredicted ACE only for EVAR. Subgroup analyses revealed that patients suffering ACE did not have higher or lower overall risk than patients who did not suffer ACE. This is the first study to address three risk calculators within a vascular operation-specific database and to show significant differences in their validity. Whereas the RCRI is expected to predict a wider range of ACEs than the NSQIP and VSGNE, it does so inadequately and thus should not be used to plan perioperative cardiovascular care in the vascular surgery patient. A previous analysis of almost 10,000 patients in the VSGNE database compared the RCRI with the VSGNE and showed similar outcomes. Although that study was more statistically robust and included a larger sample, the rates of ACE within each operation subset were comparable with those of this study. The RCRI underperformed predictability, whereas the VSGNE was more accurate. 6 The end point ACE predicted by the VSGNE has changed since the publication of the cited analysis from a wider range of ACEs including MI, CHF, and dysrhythmia to merely postoperative MI. The results of both analyses authenticate the importance of addressing adverse events within an isolated vascular population that portends its own set of hemodynamic challenges. The Society of Thoracic Surgeons created a risk calculator that is available online as well. There are seven separate calculators for specific cardiac operations, and each calculator predicts a variety of outcomes, similar to the NSQIP. The calculators have been validated with a C statistic ranging from 0.61 to 0.72. 7 The calculator has become so well respected that it is the basis for determining a patient's eligibility for transcatheter aortic valve replacement trials. 8 The VSGNE calculator has already tapped into the Society for Vascular Surgery VQI database and shows great potential as a foundation for a vascular operation risk calculator, similar to the Society of Thoracic Surgeons calculator. One argument for the substantial ACE observed at our institution could be differences in comorbidity profiles or medical management. The VSGNE calculator derivation cohort has been described, 5 and our sample had a significantly higher percentage of patients receiving aspirin therapy (82.3% vs 77.1%; P ¼ .0005) and statin therapy (76.6% vs 64.5%; P < .0001) but significantly lower percentage of patients receiving beta-blocker therapy (57.3% vs 82.9%; P < .0001). Compared with the cohort used to create the RCRI, our sample had a higher percentage of patients receiving beta-blocker therapy (57.3% vs 18.4%; P < .0001). 4 Recent meta-analysis has not shown perioperative beta-blocker therapy to reduce ACE in the vascular population. 9 None of the calculators require data on medical management, suggesting that medical therapy does not appreciably affect perioperative cardiac risk. Compared with the VSGNE derivation cohort, 5 our sample had a significantly greater percentage of patients with a history of coronary disease (P < .0001), abnormal stress test results (P < .0001), diet-or medication-controlled diabetes (P ¼ .0073), and history of CHF (P ¼ .0052 for asymptomatic; P ¼ .0419 for symptomatic). Similar trends were seen in comparing our EVAR sample with the VSGNE sample, which could possibly explain its underperformance for this operation alone. Many surrogate markers have been proposed to evaluate the risk of ACE. A preoperative blood N-terminal pro-B-type natriuretic peptide value >302 pg/mL was shown to be statistically significant for ACE (defined as MI, CHF, or primary cardiac death) in a sample of 365 patients undergoing vascular operations. 10 In patients undergoing open AAA repair, open aortoiliac and aortofemoral reconstruction, and CEA, a positive finding on dipyridamole stress echocardiography was an independent predictor for ACE (defined as cardiac-related death, MI, and unstable angina). 11 In fact, new wall motion abnormalities detected during stress echocardiography showed a positive predictive value of 38% in another elective vascular surgery-specific population. 12 Our analysis revealed that only 55% of our population underwent stress testing before their operation. Of patients who had an ACE and underwent stress testing, about 50% had a positive stress test result. The results of stress testing analysis should be viewed skeptically as there may be an apparent selection bias, and the RCRI and VSGNE calculators (for all four operations) incorporate stress test results in their risk calculations. The NSQIP and RCRI predict cardiac events other than MI, suggesting that heart failure and arrhythmias are surrogate markers for coronary disease in a population prone to atherosclerotic arterial disease. Competent vascular surgeons must use all tools at their disposal to adequately weigh the risk while maintaining stewardship of health care resources.
The cost of patients with postoperative MI is estimated to be $100,000 greater than that of their counterparts. These patients also tend to be discharged to a facility rather than home, continuing to drive the cost of care. 13 How do providers implement knowledge of preoperative risk in an environment constantly focused on cost, quality, and appropriate utilization? Medicare does reimburse for preoperative evaluations deemed medically necessary by the attending surgeon.
14 Payment for consultation would not have an impact on the compensation for a prolonged hospital stay and extensive testing involved after an ACE. There is some evidence that hospitals with higher rates of preoperative cardiology consultations have lower rates of postoperative MI in vascular surgery patients. 15 However, this has not been tested in a systematic manner, and hospitals with greater resources may benefit from more extensive cardiovascular postoperative care and patient selection bias. The limitations of this study include those pertinent to any single-center retrospective review. Future analysis could include larger samples from regional or national databases. Each calculator predicts a different cardiac complication and diagnoses MI differently, thus making direct comparison difficult. The discordance in diagnosis of MI between the different calculators could have led to discrepancy in data. However, the RCRI strongly underestimated ACE, and if CK-MB, a less sensitive marker than troponin, was used, the conclusion may have been stronger. Recent evidence debates the implementation of national surgical databases and their usefulness in improving outcomes. 16 All three risk calculators used in this study are derived from prospective registries that may create their own selection bias and potentially underpredict adverse surgical events.
CONCLUSIONS
Patients with vascular disease have a high incidence of coronary artery disease that translates to perioperative ACE. Diverse methods of risk calculator creation are reflected in their range of applicability to practice. The NSQIP and VSGNE calculators more adequately predicted ACE than the RCRI. Both calculators have stronger backgrounds in vascular surgery and take into account more modern practices. The calculation of risk cannot declare whether an event will occur, and many high-risk events do not occur, whereas low-risk events do occur. Although our data can be viewed holistically to show that risk calculators either fail or succeed to inform us about potential hurdles, calculation of risk does not eliminate ACE as a possibility. As a vascular surgery service and a health care institution, estimating risk can lead to appropriate changes in practice that can reduce the chance that an ACE will occur. 
AUTHOR CONTRIBUTIONS

